Chronic Urticaria Treatment with Omalizumab-Verification of NLR, PLR, SIRI and SII as Biomarkers and Predictors of Treatment Efficacy.

Tarkowski, Bartlomiej; Lawniczak, Julia; Tomaszewska, Katarzyna; Kurowski, Marcin; Zalewska-Janowska, Anna

Tarkowski, Bartlomiej; Lawniczak, Julia; Tomaszewska, Katarzyna; Kurowski, Marcin; Zalewska-Janowska, Anna.

Afiliação

Tarkowski B; Psychodermatology Department, Medical University of Lodz, 92-213 Lodz, Poland.
Lawniczak J; Faculty of Medicine, Medical University of Lodz, 92-213 Lodz, Poland.
Tomaszewska K; Psychodermatology Department, Medical University of Lodz, 92-213 Lodz, Poland.
Kurowski M; Department of Immunology and Allergy, Medical University of Lodz, 92-213 Lodz, Poland.
Zalewska-Janowska A; Psychodermatology Department, Medical University of Lodz, 92-213 Lodz, Poland.

J Clin Med ; 12(7)2023 Apr 01.

Article em En | MEDLINE | ID: mdl-37048721

Palavras-chave

chronic spontaneous urticaria; omalizumab; predictors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google